on 06 Aug 2024
Last Applicant/ Owned by
140 First Street
Cambridge
MA
02141
Serial Number
98118232 filed on 04th Aug 2023
Registration Number
7469817 registered on 06th Aug 2024
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory Read More
Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
11th Oct 2023
11th Oct 2023
No 98118232
No Service/Collective Mark
No V03222000601
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
03rd Jul 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
03rd Jul 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
29th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
29th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
07th Mar 2024 | TEAS STATEMENT OF USE RECEIVED |
07th Mar 2024 | USE AMENDMENT FILED |
27th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
02th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |